Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lizard Labs is a specialized chemical manufacturing company based in the Netherlands, primarily known for the synthesis and wholesale distribution of novel psychoactive substances (NPS). The company gained prominence for its production of lysergamide derivatives, including 1P-LSD, 1cP-LSD, and 1V-LSD, which are marketed as research chemicals. While their products are officially sold for laboratory use and not for human consumption, they are widely recognized in the pharmacology community for their high-purity synthesis of psychedelic compounds. Lizard Labs operates as a primary supplier for numerous retail research chemical vendors globally, maintaining a reputation for consistent quality in a largely unregulated market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lizard Labs.